ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience / 부인종양
Journal of Gynecologic Oncology
; : 6-2020.
Article
en En
| WPRIM
| ID: wpr-782096
Biblioteca responsable:
WPRO
ABSTRACT
1.1 g/dL, estimated glomerular filtration rate (eGFR) ≤60 mL/min, ≥3 comorbidities were independently associated with a higher severe toxicity.CONCLUSIONS: Elderly patients with EOC can safely be treated with bevacizumab; factors other than age, as higher creatinine serum levels, eGFR and number of comorbidities should be considered to better estimate bevacizumab-related toxicity risk.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Neoplasias Ováricas
/
Estudios de Casos y Controles
/
Comorbilidad
/
Modelos Logísticos
/
Creatinina
/
Diagnóstico
/
Quimioterapia
/
Bevacizumab
/
Tasa de Filtración Glomerular
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Journal of Gynecologic Oncology
Año:
2020
Tipo del documento:
Article